Dr David Mosedale

David Mosedale graduated from Girton College, Cambridge University in 1993 and completed his Ph.D. degree, under the supervision of Prof. Jim Metcalfe and Dr. David Grainger, in 1996. Since then, he has been employed as a post-doctoral research fellow in the Inflammation Research and Therapy group in the Department of Medicine, University of Cambridge. Dr. Mosedale's research interests include developing new antibody-based detection methods (he pioneered the application of quantitative immunofluoresence technology) and more recently in the application of these methods to the epidemiology of heart disease. In 2003, David was promoted to Principle Investigator at the Translational Research Unit, Papworth Hospital NHS Trust, where his research is focussed on the epidemiology of heart disease, with particular interest in the role of inflammatory cytokines. Dr Mosedale is also Chairman of the management commitee of the MaGiCAD (Metabonomic and Genomic Investigation of Coronary Artery Disease) study. In 2006, David took on a role as Vice President of Research & Development for the Cambridge biotechnology company Pronostics Ltd, but he remains an active member of the group